Skip to Content

Join the 'Breast Cancer, Metastatic' group to help and get support from people like you.

Breast Cancer, Metastatic News

Related terms: Metastatic Breast Cancer

Breast Cancer More Lethal for Blacks Than Whites

Posted 1 day 9 hours ago by Drugs.com

MONDAY, Oct. 16, 2017 – Differences in insurance are a major reason why black women are more likely to die of breast cancer than white women in the United States, a new study contends. "We found that differences in insurance explained one-third of the total excess risk of death in non-elderly black women compared to white women diagnosed with early stage breast cancer, while differences in tumor characteristics explained approximately one-fifth of the excess risk," lead study author Ahmedin Jemal, of the American Cancer Society (ACS), and colleagues wrote. In 2014, breast cancer death rates were 41 percent higher among black women than among white women in the United States, the researchers said. To learn more about this disparity, the investigators looked at information on more than 550,000 non-elderly women with early stage breast cancer. Black women were more likely to be uninsured ... Read more

Related support groups: Depo-Provera, Provera, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Anastrozole, Breast Cancer, Metastatic, Letrozole, Megestrol, Evista, Zoladex, Megace, Aromasin, Casodex, Breast Cancer - Adjuvant, Exemestane

More Women Choose Breast Reconstruction After Mastectomy

Posted 4 days ago by Drugs.com

FRIDAY, Oct. 13, 2017 – Over five years, the proportion of U.S. breast cancer patients opting for breast reconstruction after mastectomy grew by about two-thirds, a new government report shows. An analysis of patient data shows breast reconstruction followed 40 percent of breast-removal surgeries in 2014 – up from less than one-quarter in 2009, according to the U.S. Agency for Healthcare Research and Quality (AHRQ). Among age groups, women aged 65 and older accounted for the largest increase in breast reconstructive surgery – 140 percent. "This type of information is essential for policymakers and health systems seeking to keep pace with important trends in clinical care," Gopal Khanna, agency director, said in an AHRQ news release. The overall increase during the study period was 65 percent, researchers said. While reconstruction procedures increased in all insurance groups, the ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

Breast Cancer Screenings Still Best for Early Detection

Posted 5 days ago by Drugs.com

THURSDAY, Oct. 12, 2017 – Breast cancer is the second leading cause of cancer death among women in the United States, and routine screenings remain the most reliable way to detect the disease early, a breast cancer expert says. "Breast cancer can be treated more successfully if detected in its early phases, while it is small and has not yet spread," said Dr. Kathryn Evers, director of mammography at Fox Chase Cancer Center in Philadelphia. "With today's state-of-the-art treatment options and less extensive surgery, patients are experiencing better outcomes." Older age is a leading risk factor for breast cancer. Most women are diagnosed after the age of 50. Having certain mutations in the BRCA1 and BRCA2 genes also predispose women to the disease. And there are some lifestyle-related risk factors that can be controlled, such as hormone therapy after menopause, obesity, alcohol intake ... Read more

Related support groups: Cancer, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention, Breast Cancer - Palliative

Hormone Therapy May Be OK for Women With Migraines

Posted 6 days ago by Drugs.com

WEDNESDAY, Oct. 11, 2017 – Women who suffer from migraines may be able to safely use hormone therapy to treat menopause symptoms, a new study suggests. The study of 85,000 U.S. women found no evidence that hormone therapy carried a particular risk of heart attack or stroke among those with a history of migraine headaches. That possibility has been a concern, mainly based on studies of younger women with migraines. Those studies linked hormonal birth control pills to a small risk of stroke, particularly among women whose migraines feature "aura" symptoms – most often, visual disturbances such as seeing zigzag lines or bright flashes. Less has been known about any risks of hormone replacement therapy, said Dr. Jelena Pavlovic, the lead researcher on the new study. "It appears safe for women with migraines to use hormone therapy, in terms of their cardiovascular risk," said Pavlovic, an ... Read more

Related support groups: Plan B, Migraine, Mirena, Nexplanon, Depo-Provera, Provera, NuvaRing, Sprintec, Implanon, Ortho Tri-Cyclen, Hot Flashes, Tri-Sprintec, Microgestin Fe 1/20, Yasmin, Plan B One-Step, Loestrin 24 Fe, Ortho Evra, Ischemic Stroke, Breast Cancer, TriNessa

Double Mastectomy Increases Time Spent Off Work

Posted 8 days ago by Drugs.com

MONDAY, Oct. 9, 2017 – Working women who choose an aggressive treatment for breast cancer are likely to miss a significant amount of time before returning to the job. That's the conclusion of a study that focused on approximately 1,000 women in Georgia and Los Angeles who had to decide between various options for dealing with their cancer diagnosis. More than 60 percent of the women, aged 20 to 79, chose a lumpectomy, a relatively less aggressive intervention. One-third chose chemotherapy, while 16 percent had one breast removed (a unilateral mastectomy), the study authors said. Another 23 percent had both breasts removed (a bilateral mastectomy), which is considered the most aggressive option. Nearly 85 percent of the women had been working full-time prior to their diagnosis. Those who chose a bilateral mastectomy with breast reconstruction were eight times more likely to miss over a ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

FDA Approves Verzenio (abemaciclib) for Certain Advanced or Metastatic Breast Cancers

Posted 17 days ago by Drugs.com

September 28, 2017 – The U.S. Food and Drug Administration today approved Verzenio (abemaciclib) to treat adult patients who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer that has progressed after taking therapy that alters a patient’s hormones (endocrine therapy). Verzenio is approved to be given in combination with an endocrine therapy, called fulvestrant, after the cancer had grown on endocrine therapy. It is also approved to be given on its own, if patients were previously treated with endocrine therapy and chemotherapy after the cancer had spread (metastasized). "Verzenio provides a new targeted treatment option for certain patients with breast cancer who are not responding to treatment, and unlike other drugs in the class, it can be given as a stand-alone treatment to patients who were previously ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Abemaciclib, Verzenio

Verzenio Approved for Advanced Breast Cancer

Posted 18 days ago by Drugs.com

FRIDAY, Sept. 29, 2017 – Verzenio (abemaciclib) has been approved by the U.S. Food and Drug Administration to treat women with certain advanced forms of breast cancer, the most common cancer in the United States. More than 250,000 women are projected to be diagnosed with breast cancer this year, and more than 40,000 will die of the disease, the U.S. National Cancer Institute estimates. Verzenio is designed to block substances called cyclin-dependent kinases that are thought to spur the growth of cancer cells. The drug is approved for hormone receptor-positive and HER2-negative forms of advanced or spreading breast cancer that have been treated with a therapy that changes a person's hormones (endocrine therapy). "Verzenio provides a new targeted treatment option for certain patients with breast cancer who are not responding to treatment, and unlike [similar drugs], it can be given as a ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Mastectomy Study Confirms 'Jolie Effect'

Posted 25 Sep 2017 by Drugs.com

MONDAY, Sept. 25, 2017 – Actress Angelina Jolie's decision to undergo breast removal to reduce her risk of breast cancer has led other women to do so, a new study shows. The findings show that celebrities can influence the health care decisions of the general public, said study author Art Sedrakyan, a professor at Weill Cornell Medicine in New York City. In early 2013, Jolie announced her decision to have the preventive surgery to have both breasts removed due to her elevated genetic risk for breast cancer. Researchers sought to determine the impact of that news by analyzing 2004-2014 data on risk-reducing mastectomy in New York State and New South Wales in Australia. In New York, they found the number of women undergoing the procedure nearly doubled – rising from 3.3 bimonthly cases per 1 million 20 months before Jolie's announcement to 6.3 cases per 1 million 20 months after her ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Breast Cancer Radiation 'Less Scary' Than Thought

Posted 25 Sep 2017 by Drugs.com

MONDAY, Sept. 25, 2017 – Radiation therapy for breast cancer is actually "less scary" than anticipated, nine out of 10 patients say after treatment. A survey of 300-plus breast cancer patients also found that more than 80 percent said the side effects of radiation were better than expected. "The word radiation itself sounds frightening and is associated with many negative news stories," said lead researcher Dr. Narek Shaverdian, of the University of California, Los Angeles (UCLA). But over the last 20 years, significant advances have been made, said Shaverdian, chief resident in radiation oncology at UCLA's David Geffen School of Medicine. "These changes allow us to spare critical organs, create an individual radiation plan for each patient, and also deliver radiation in more convenient schedules," he explained. Shaverdian and his team surveyed patients who had received radiation while ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Nausea/Vomiting - Radiation Induced, Osteolytic Bone Metastases of Breast Cancer, History - Radiation Therapy

Surgeons Play Big Role in Women's Choices for Breast Cancer Care

Posted 13 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 13, 2017 – A breast cancer patient's choice of surgeon can have a major effect on her treatment, according to a new study. That's because surgeons have a strong influence on whether early stage cancer patients have both breasts removed even when cancer is found in only one breast – a procedure called contralateral prophylactic mastectomy (CPM). Researchers surveyed more than 3,300 women with early stage breast cancer and 349 surgeons who treated them. About 16 percent of the patients had both breasts removed. Only 4 percent of those whose surgeons heavily favored breast-saving surgery and were most reluctant to remove both breasts had the procedure. That compared to 34 percent of patients whose surgeons were most willing to do the surgery, the study found. "That difference is huge. Even for a procedure that is very patient-driven, we see that surgeons account for a ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Surgical Prophylaxis, Breast Cancer - Palliative

Breast Cancer Patients On Opioid Treatment More Likely To Discontinue Hormones

Posted 11 Sep 2017 by Drugs.com

MONDAY, Sept. 11, 2017 – Breast cancer patients who take opioid painkillers are more likely to discontinue an important hormone treatment that helps ensure their survival, researchers report. Use of prescription opioids such as OxyContin (oxycodone) and Vicoprofen (hydrocodone) was "significantly associated" with failure to adhere to the hormone therapy and a higher risk of death, the study found. "It's not a big secret that the U.S. uses more opioids than any other country in the world," said researcher Rajesh Balkrishnan, of the University of Virginia School of Medicine's department of public health sciences. "Clearly there has to be better management of opioids in the elderly cancer population," Balkrishnan said in a university news release. For the study, researchers analyzed follow-through rates for adjuvant endocrine therapy – commonly called hormone treatment – among more than ... Read more

Related support groups: OxyContin, Breast Cancer, Tamoxifen, Arimidex, Anastrozole, Breast Cancer, Metastatic, Vicoprofen, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Tamoxifen Hexal, Nolvadex, Tamofen, Tamosin, Genox, Nolvadex D, Soltamox, Tamone, Emblon, Tamoxen

Many Terminal Cancer Patients Remain in Denial

Posted 20 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – Nearly 10 percent of patients with terminal cancer don't want to know they're dying, which can make their final days more difficult, a new study finds. Unwillingness to face poor prospects can lead to unnecessary treatments and keep patients from making end-of-life plans, the researchers reported recently in The Oncologist. "Health care professionals should appropriately assess patients' readiness for prognostic information," said study leader Siew-Tzuh Tang, a professor at Chang Gung University School of Nursing in Taiwan. Doctors should respect patients' reluctance to confront their poor prognosis if they are not ready to know, "but sensitively coach them to cultivate their accurate prognostic awareness," Tang said in a journal news release. The study involved nearly 250 terminal cancer patients in Taiwan. They were questioned several times over their last ... Read more

Related support groups: Anxiety, Generalized Anxiety Disorder, Anxiety and Stress, Cancer, Post Traumatic Stress Disorder, Social Anxiety Disorder, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Skin Cancer, Ovarian Cancer, Pancreatic Cancer, Cervical Cancer, Stomach Cancer, Breast Cancer, Prevention

Nerlynx Approved to Help Prevent Breast Cancer's Return

Posted 18 Jul 2017 by Drugs.com

TUESDAY, July 18, 2017 – Nerlynx (neratinib) has been approved by the U.S. Food and Drug Administration to help prevent HER2-positive breast cancer from returning. It's the first drug designed to prevent return of HER2-positive breast cancer, a genetic form of the disease that's particularly aggressive and can spread to other parts of the body, the agency said in a news release. The drug is meant for what's known as extended adjuvant therapy – given after initial treatment, to further reduce the risk that cancer will return. Breast cancer is the most common form of cancer in the United States, the FDA said. The disease is projected to be diagnosed in more than 250,000 women this year, and more than 46,000 are likely to die of the disease, according to the U.S. National Cancer Institute. Nerlynx, among a class of drugs designed to block enzymes that fuel cancer-cell growth, was ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Nerlynx, Neratinib

Most Breast Cancer Patients Have Help Choosing Treatments

Posted 10 Jul 2017 by Drugs.com

MONDAY, July 10, 2017 – Most women who've been diagnosed with breast cancer don't go it alone. Many breast cancer patients depend on family and friends to help them make treatment decisions, get to doctor appointments and seek out other resources. A new study finds half of women rely on three or more people to help them through it. "People just diagnosed with cancer are often scared and overwhelmed. Having another person to help them process information is important," said study lead author Lauren Wallner, an assistant professor of general medicine and epidemiology at the University of Michigan. "Physicians need to recognize that women involve other people in their treatment decisions," she added in a university news release. "These people represent an important group to provide information about treatment options." For the study, the researchers surveyed about 2,500 women who had ... Read more

Related support groups: Depo-Provera, Provera, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Gleevec, Anastrozole, Breast Cancer, Metastatic, Letrozole, Megestrol, Evista, Zoladex, Megace, Tasigna, Sprycel, Herceptin

2 of 3 Americans Don't Have 'Advance Directive' for End of Life

Posted 7 Jul 2017 by Drugs.com

FRIDAY, July 7, 2017 – Most people don't like talking about dying, especially their own death. But it's important to let your loved ones know how you'd like your medical care handled when your "time" comes. Yet, new research found that two-thirds of American adults haven't completed an advance directive. That's a legal document that outlines a person's wishes if they become incapacitated and can't make their own health care decisions, particularly near the end of life. "Most experts agree that some form of written directives are a key component of advance care planning, and yet rates of completion are low and do not appear to be increasing," said study leader Dr. Katherine Courtright. She is an instructor at the University of Pennsylvania's Palliative and Advanced Illness Research Center. "We need to address common barriers to completing these important documents on a national level, ... Read more

Related support groups: Cancer, Breast Cancer, Ankylosing Spondylitis, Colorectal Cancer, Breast Cancer, Metastatic, Breast Cancer - Palliative, Gastric Cancer

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer

Related Drug Support Groups

tamoxifen, Arimidex, Femara, anastrozole, letrozole, Xeloda, Herceptin, Taxol, Taxotere, view more... capecitabine, Faslodex, Ibrance, paclitaxel, Gemzar, gemcitabine, eribulin, docetaxel, Abraxane, bevacizumab, Tykerb, Perjeta, Fareston, Kadcyla, fulvestrant, Kisqali, Tamoxifen Hexal, lapatinib, Nolvadex, pertuzumab, trastuzumab, Ixempra, paclitaxel protein-bound, toremifene, Docefrez, Halaven, Tamosin, ribociclib, Tamoxen, Onxol, Nolvadex D, Tamofen, Emblon, Tamone, ixabepilone, Soltamox, ado-trastuzumab emtansine, palbociclib, Genox